Pulled from shelves: Zantac causing cancer?

CVS has suspended sales of products containing ranitidine, a popular heartburn medication marketed as Zantac, after the US Food and Drug Administration (FDA) announced that an impurity present in low levels in ranitidine may cause cancer. RT America’s Trinity Chavez reports for the News with Rick Sanchez.

Be the first to comment

Leave a Reply

Your email address will not be published.


Time limit is exhausted. Please reload the CAPTCHA.